vTv Therapeutics (VTVT) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for vTv Therapeutics (VTVT) over the last 11 years, with Q4 2024 value amounting to $508000.0.
- vTv Therapeutics' Accumulated Depreciation & Amortization rose 431.21% to $508000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $508000.0, marking a year-over-year increase of 431.21%. This contributed to the annual value of $508000.0 for FY2024, which is 431.21% up from last year.
- As of Q4 2024, vTv Therapeutics' Accumulated Depreciation & Amortization stood at $508000.0, which was up 431.21% from $487000.0 recorded in Q4 2023.
- In the past 5 years, vTv Therapeutics' Accumulated Depreciation & Amortization ranged from a high of $508000.0 in Q4 2024 and a low of $216000.0 during Q4 2020
- Over the past 5 years, vTv Therapeutics' median Accumulated Depreciation & Amortization value was $397000.0 (recorded in 2022), while the average stood at $382600.0.
- Per our database at Business Quant, vTv Therapeutics' Accumulated Depreciation & Amortization surged by 4594.59% in 2020 and then surged by 431.21% in 2024.
- Over the past 5 years, vTv Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $216000.0 in 2020, then soared by 41.2% to $305000.0 in 2021, then soared by 30.16% to $397000.0 in 2022, then increased by 22.67% to $487000.0 in 2023, then rose by 4.31% to $508000.0 in 2024.
- Its Accumulated Depreciation & Amortization was $508000.0 in Q4 2024, compared to $487000.0 in Q4 2023 and $397000.0 in Q4 2022.